Alpha Teknova, Inc. (TKNO) stock
TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30150% above fair value
$8.29−0.32 (-3.77%)
Close on Nov 12, 2026Market cap $445.34MP/E –Yield –
Alpha Teknova enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Alpha Teknova's enterprise value was $445.31M on Nov 11, 2026, against $228.38M a year earlier. Over the last 5 years it ranged from $29.05M to $475.67M, with a median of $168.81M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $445.31M | +145.7% |
| 2025 | Dec 31, 2025 | $181.28M | -57.5% |
| 2024 | Dec 31, 2024 | $426.77M | +221.0% |
| 2023 | Dec 29, 2023 | $132.97M | +22.2% |
| 2022 | Dec 30, 2022 | $108.80M | -77.1% |
| 2021 | Dec 31, 2021 | $475.67M | – |
See a number that looks wrong?